Mike Ligalig News

In the largest gene sequencing study of autism spectrum disorder, Mount Sinai researchers have identified 102 genes associated with risk for autism NEW YORK (PRWEB) JANUARY 23, 2020 In the largest genetic sequencing study of autism spectrum disorder (ASD) to date, researchers have identified 102 genes associated with risk for autism.[…]

Annual Distinguished Scholar Award Aims to Break Down Barriers to Equity in Medical Research NEW YORK (PRWEB) JANUARY 23, 2020 The Icahn School of Medicine at Mount Sinai—an international leader in medical and scientific training, biomedical research, and patient care—today announced the recipients of the first-of-its-kind Distinguished Scholar Award, a new[…]

DelawareBio, a nonprofit trade organization with the mission of catalyzing growth in the state’s life-science industry, presents a panel discussion on gene editing that goes beyond CRISPR technology. To be held Thursday, February 6th from 1:30-5pm at the ChristianaCare John H. Ammon Medical Education Center, the event will provide an[…]

Mr. Thorne is a seasoned executive and noted investor who has worked in a number of industries in senior leadership positions. SAN DIEGO (PRWEB) JANUARY 23, 2020 Cytonus Therapeutics Inc. today announced the appointment of Christopher Thorne as Chairman. Mr. Thorne is a noted investor, tech entrepreneur, and former senior management[…]

The partnership will focus on supporting individuals who want to re-enter the workforce in the fields of data analytics and cloud computing. The R2: Retool & Return Program combines NOVA’s tech training in cloud computing and data analytics with FlexProfessionals’ job-search readiness training and support. Students are able to enroll[…]

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today welcomed the news that DiaMedica Therapeutics has received U.S. Food and Drug Administration (FDA) approval to commence Phase 2 clinical trials of its lead candidate, DM199, for[…]

InstantGMP, Inc., the company behind the affordable all-in-one manufacturing and quality software solution InstantGMP™ PRO, announces a new partnership with learning management company Entrenar.se. This collaboration will simplify and even automate crucial aspects of training and documentation for companies regulated by the U.S. Food and Drug Administration, making it much[…]

Expansion Meets Industry Demand for Pre-Clinical Models for Cancer and Environmental Research STATE COLLEGE, PA. (PRWEB) JANUARY 23, 2020 INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has announced the addition of four zebrafish assays to its portfolio. These additions both expand INDIGO’s robust portfolio of in vitro animal[…]

ixLayer, a San Francisco based start-up is launching a first of its kind platform to simplify the complex relationship between precision health tests, physicians, and patients. SAN FRANCISCO (PRWEB) JANUARY 23, 2020 ixLayer, a San Francisco based start-up is launching a first of its kind platform to simplify the complex relationship[…]

Catalent, a global leader in clinical supply services, today announced the launch of FlexDirect™, a new direct-to-patient service for clinical trials. The FlexDirect service provides sponsors with the choice of site-to-patient distribution, or Catalent’s new pharmacy-to-patient service, both of which can be combined with standard distribution of clinical supplies to[…]